Stokes Tim, Tumilty Emma, Latu Anna Tiatia Fa'atoese, Doolan-Noble Fiona, Baxter Jo, McAuley Kathryn, Hannah Debbie, Donlevy Simon, Dummer Jack
Department of General Practice and Rural Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand
Institute for Translational Sciences, University of Texas Medical Branch School of Health Professions, Galveston, Texas, USA.
BMJ Open. 2019 Nov 24;9(11):e033524. doi: 10.1136/bmjopen-2019-033524.
Chronic obstructive pulmonary disease (COPD) is a common chronic disease with significant morbidity and mortality, particularly for Māori, which places a large burden on the New Zealand (NZ) health system. We undertook a qualitative study as part of a mixed-methods implementation research project which aimed to determine the barriers and enablers to the provision of accessible high-quality COPD care.
Southern Health Region of NZ (Otago and Southland).
Thirteen health professional stakeholders and 23 patients with severe COPD (including one Māori and one Pasifika participant).
Semistructured interviews were undertaken. A thematic analysis using the Levesque conceptual framework for access to healthcare was conducted.
Health professional stakeholders identified barriers to providing access to health services, in particular: availability (inadequate staffing and resourcing of specialist services and limited geographical availability of pulmonary rehabilitation), affordability (both of regular medication, medication needed for an exacerbation of COPD and the copayment charge for seeing a general practitioner) and appropriateness (a shared model of care across primary and secondary care was needed to facilitate better delivery of key interventions such as pulmonary rehabilitation and advance care planning (ACP). Māori stakeholders highlighted the importance of communication and relationships and the role of whānau (extended family) for support. Patients' accounts showed variable ability to access services through having a limited understanding of what COPD is, a limited knowledge of services they could access, being unable to attend pulmonary rehabilitation (due to comorbidities) and direct (medication and copayment charges) and indirect (transport) costs.
People with severe COPD experience multilevel barriers to accessing healthcare in the NZ health system along the pathway of care from diagnosis to ACP. These need to be addressed by local health services if this group of patients are to receive high-quality care.
慢性阻塞性肺疾病(COPD)是一种常见的慢性疾病,发病率和死亡率都很高,尤其是对毛利人来说,给新西兰(NZ)卫生系统带来了巨大负担。作为一项混合方法实施研究项目的一部分,我们开展了一项定性研究,旨在确定提供可及的高质量慢性阻塞性肺疾病护理的障碍和促进因素。
新西兰南部卫生区(奥塔哥和南地)。
13名卫生专业利益相关者和23名重度慢性阻塞性肺疾病患者(包括1名毛利人和1名太平洋岛民参与者)。
进行半结构化访谈。使用Levesque获得医疗保健的概念框架进行主题分析。
卫生专业利益相关者确定了提供卫生服务可及性方面的障碍,特别是:可获得性(专科服务人员配备和资源不足,以及肺康复的地理可及性有限)、可负担性(包括常规药物、慢性阻塞性肺疾病急性加重所需药物以及看全科医生的自付费用)和适宜性(需要初级和二级保健之间的共享护理模式,以促进更好地提供关键干预措施,如肺康复和预立医疗照护计划(ACP))。毛利人利益相关者强调了沟通和关系的重要性以及大家庭提供支持的作用。患者的叙述表明,他们获取服务的能力各不相同,原因包括对慢性阻塞性肺疾病是什么了解有限、对可获得的服务了解有限、因合并症无法参加肺康复以及直接(药物和自付费用)和间接(交通)成本。
重度慢性阻塞性肺疾病患者在从诊断到预立医疗照护计划的护理过程中,在新西兰卫生系统中获取医疗保健面临多层次障碍。如果要让这群患者获得高质量护理,当地卫生服务机构需要解决这些问题。